Lloyd Johnston
Net worth: 80 571 $ as of 2024-06-29
Profile
Lloyd Johnston worked as Vice President-Operations at Alkermes, Inc. from 2004 to 2008.
He then served as COO and Senior Vice President-Research & Development at Selecta Biosciences, Inc. from 2014 to 2023.
Prior to that, he was a Member at Advanced Inhalation Research, Inc. in 1998 and 1999.
Currently, he is the Chief Operating Officer at Cartesian Therapeutics, Inc. Dr. Johnston completed his undergraduate degree at Queen's University.
He further pursued his education at the Massachusetts Institute of Technology, where he obtained graduate and doctorate degrees.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.02% | 2024-04-17 | 2,983 ( 0.02% ) | 80 571 $ | 2024-06-29 |
Former positions of Lloyd Johnston
| Companies | Position | End |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Chief Operating Officer | 2023-11-12 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Chief Operating Officer | 2007-12-31 |
Advanced Inhalation Research, Inc.
 Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Advanced Inhalation Research, Inc. is a company that develops dry-powder drug delivery systems for respiratory patients. The company is based in Cambridge, MA. The company was founded by Terrance G. McGuire, Justin S. Hanes. Advanced Inhalation Research was acquired by Alkermes, Inc., part of Alkermes Plc from September 16, 2011 on February 01, 1999 for $114.54 million. | Corporate Officer/Principal | 1998-12-31 |
Training of Lloyd Johnston
| Massachusetts Institute of Technology | Doctorate Degree |
| Queen's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Advanced Inhalation Research, Inc.
Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Advanced Inhalation Research, Inc. is a company that develops dry-powder drug delivery systems for respiratory patients. The company is based in Cambridge, MA. The company was founded by Terrance G. McGuire, Justin S. Hanes. Advanced Inhalation Research was acquired by Alkermes, Inc., part of Alkermes Plc from September 16, 2011 on February 01, 1999 for $114.54 million. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Stock Market
- Insiders
- Lloyd Johnston
